MLEC Overview

Moolec Science SA is a science based food ingredient company. The Company focuses on the production of animal proteins within plants by using molecular farming technology. It operates globally across the United States, Europe, and South America. The Company’s product portfolio and pipeline focus on improving the agronomic efficiency of widely used crops such as soy, pea, and safflower. Its product portfolio includes GLASO, PIGGY SOOY, VALORASOY, and MYCOFOOD. The Company’s GLASO product is a genetically engineered safflower variety designed to produce higher levels of gamma linolenic acid (GLA). Its PIGGY SOOY product is a bioengineered soybean that contains pig proteins used in creating meat like textures and food ingredients. The Company also has a growing international patent portfolio of approximately 25 patents, both granted and pending, for its technology.

Wall Street analysts forecast MLEC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MLEC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Moolec Science SA revenue for the last quarter amounts to 2.64M USD, increased 948.32

Moolec Science SA. EPS for the last quarter amounts to -9.35 USD, increased 32.06

Moolec Science SA (MLEC) has 52 emplpoyees as of March 11 2026.

Today MLEC has the market capitalization of 7.61M USD.